Company Capital Raisings
NOTE: The ATM capital raising event is an aggregate sum of transactions reported as of current date. The price is the weighted average price of total transactions.
| Company |
BeiGene, Ltd. |
| Ticker Symbol |
BGNE |
| CUSIP Number |
07725L102 (Active) |
| US ISIN |
US07725L1026 |
| Country |
China-Test |
| Security Type |
ADR |
| Listing Exchange |
NASDAQ |
| Ratio (ORD:DR) |
13 :1 |
| Date |
Shares # |
Price $ |
Value $ |
Event Type |
Lead Manager |
1st Co-Manager |
2nd Co-Manager |
Issuer's US Counsel |
Issuer's Local Counsel |
| 12/4/2020 |
1,632,700 |
225.00 |
367,357,500 |
Other |
Goldman Sachs |
|
|
Goodwin Procter LLP |
Fangda Partners |
| 1/22/2018 |
7,920,800 |
101.00 |
800,000,800 |
Follow-On |
Goldman Sachs |
Morgan Stanley |
Leerink Partners |
Davis Polk & Wardwell LLP |
Mourant Ozannes |
| 8/16/2017 |
2,834,750 |
71.00 |
201,267,250 |
Follow-On |
Morgan Stanley |
Goldman Sachs |
|
|
|
| 11/23/2016 |
7,100,000 |
32.00 |
227,200,000 |
Follow-On |
Goldman Sachs |
Morgan Stanley |
Cowen & Co |
|
|
| 2/8/2016 |
7,590,000 |
24.00 |
182,160,000 |
IPO |
Goldman Sachs |
Morgan Stanley |
Cowen & Co |
Goodwin Procter LLP |
Mourant Ozannes |
Click here to search Capital Raisings for other DR programs
NOTE: The ATM capital raising event is an aggregate sum of transactions reported as of current date. The price is the weighted average price of total transactions.
|